Literature DB >> 18845127

Physarum polymalic acid hydrolase: Recombinant expression and enzyme activation.

Wolfgang Mueller1, Markus Haindl, Eggehard Holler.   

Abstract

As a platform for syntheses of nanoconjugates in antitumor drug delivery, polymalic acid together with its tailoring specific exohydrolase is purified from plasmodium cultures of the slime mold Physarum polycephalum, a member of the phylum myxomycota. Polymalic acid hydrolase is expressed in an inactive form that functions as a molecular adapter for polymalic acid trafficking within the plasmodium and is activated only during secretion. Activation follows specific protein tyrosine phosphorylation and dissociation from plasma membranes. Purified inactive Physarum polymalic acid hydrolase, recombinantly expressed in yeast Saccharomyces, is activated on a preparative basis by the addition of plasma membrane fragments from plasmodia of P. polycephalum. Activation of polymalic acid hydrolase and inhibition of polymalic acid synthesis by protein tyrosine phosphorylation are complementary events and could indicate a joint signal response to plasma membrane damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845127     DOI: 10.1016/j.bbrc.2008.09.127

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

Review 1.  Biosynthetic Polymalic Acid as a Delivery Nanoplatform for Translational Cancer Medicine.

Authors:  Jianguo Zhang; Deyu Chen; Guoxin Liang; Wenrong Xu; Zhimin Tao
Journal:  Trends Biochem Sci       Date:  2020-10-22       Impact factor: 13.807

Review 2.  Polymalic acid for translational nanomedicine.

Authors:  Xing Huang; Liusheng Xu; Hui Qian; Xinghuan Wang; Zhimin Tao
Journal:  J Nanobiotechnology       Date:  2022-06-21       Impact factor: 9.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.